Rocket Pharmaceuticals Presents Positive Clinical Data from its Fanconi Anemia and Leukocyte Adhesion Deficiency-I Programs at the 62nd American Society of Hematology Annual Meeting
Go back to Rocket Pharmaceuticals Presents Positive Clinical Data from its Fanconi Anemia and Leukocyte Adhesion Deficiency-I Programs at the 62nd American Society of Hematology Annual Meeting| (NASDAQ: RCKT) | Delayed: 3.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.86 | 52 Week High | $ | |||
| Open | $3.86 | 52 Week Low | $ | |||
| Day High | $3.86 | P/E | N/A | |||
| Day Low | $3.86 | EPS | $ | |||
| Volume | 91 | |||||
